These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20621113)

  • 1. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
    Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.
    Doyle TM; Li C; Bucher DJ; Hashem AM; Van Domselaar G; Wang J; Farnsworth A; She YM; Cyr T; He R; Brown EG; Hurt AC; Li X
    Biochem Biophys Res Commun; 2013 Nov; 441(1):226-9. PubMed ID: 24140051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines.
    Xu K; Li C; Gravel C; Jiang Z; Jaentschke B; Van Domselaar G; Li X; Wang J
    Sci Rep; 2018 Jan; 8(1):1067. PubMed ID: 29348625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difficulties in standardizing the neuraminidase content of influenza vaccines.
    Gérentes L; Kessler N; Aymard M
    Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Van Domselaar G; He R; Li X
    J Vis Exp; 2011 Apr; (50):. PubMed ID: 21490585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins.
    Chun S; Li C; Van Domselaar G; Wang J; Farnsworth A; Cui X; Rode H; Cyr TD; He R; Li X
    Vaccine; 2008 Nov; 26(48):6068-76. PubMed ID: 19007587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus.
    Hashem AM; Van Domselaar G; Li C; Wang J; She YM; Cyr TD; Sui J; He R; Marasco WA; Li X
    Biochem Biophys Res Commun; 2010 Dec; 403(2):247-51. PubMed ID: 21078301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly protective human antibodies that target the active site of influenza virus neuraminidase.
    Stadlbauer D; Zhu X; McMahon M; Turner JS; Wohlbold TJ; Schmitz AJ; Strohmeier S; Yu W; Nachbagauer R; Mudd PA; Wilson IA; Ellebedy AH; Krammer F
    Science; 2019 Oct; 366(6464):499-504. PubMed ID: 31649200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
    Sylte MJ; Hubby B; Suarez DL
    Vaccine; 2007 May; 25(19):3763-72. PubMed ID: 17350145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified viral neuraminidase vaccine to control influenza.
    Arora DJ
    Can Med Assoc J; 1979 Dec; 121(12):1575-9. PubMed ID: 394829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
    Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
    Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
    J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and optimization of a multiplex anti-influenza peptide immunoassay.
    Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR
    J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.